中国实用医刊
中國實用醫刊
중국실용의간
Chinese Journal of Practical Medicine
2015年
24期
85-87
,共3页
原发性醛固酮增多症%螺内酯%临床疗效
原髮性醛固酮增多癥%螺內酯%臨床療效
원발성철고동증다증%라내지%림상료효
Primary aldosteronism%Spironolactone%Clinical efficacy
目的 探讨螺内酯治疗原发性醛固酮增多症的临床应用效果.方法 对62例原发性醛固酮增多症患者临床资料进行回顾性分析,所有患者均经临床常规药物联合螺内酯治疗.记录其治疗前后尿醛固酮、血浆醛固酮变化情况及不良反应发生率,给予统计学分析后得出结论.结果 62例原发性醛固酮增多症患者经常规治疗基础上加用螺内酯联合给药后,其尿醛固酮及血浆醛固酮检验水平均较治疗前有所下降,差异有统计学意义(P＜0.05).结论 原发性醛固酮增多症患者经常规治疗基础上加入螺内酯联合给药可获得满意临床疗效,有效保障其生活质量及生命安全.
目的 探討螺內酯治療原髮性醛固酮增多癥的臨床應用效果.方法 對62例原髮性醛固酮增多癥患者臨床資料進行迴顧性分析,所有患者均經臨床常規藥物聯閤螺內酯治療.記錄其治療前後尿醛固酮、血漿醛固酮變化情況及不良反應髮生率,給予統計學分析後得齣結論.結果 62例原髮性醛固酮增多癥患者經常規治療基礎上加用螺內酯聯閤給藥後,其尿醛固酮及血漿醛固酮檢驗水平均較治療前有所下降,差異有統計學意義(P＜0.05).結論 原髮性醛固酮增多癥患者經常規治療基礎上加入螺內酯聯閤給藥可穫得滿意臨床療效,有效保障其生活質量及生命安全.
목적 탐토라내지치료원발성철고동증다증적림상응용효과.방법 대62례원발성철고동증다증환자림상자료진행회고성분석,소유환자균경림상상규약물연합라내지치료.기록기치료전후뇨철고동、혈장철고동변화정황급불량반응발생솔,급여통계학분석후득출결론.결과 62례원발성철고동증다증환자경상규치료기출상가용라내지연합급약후,기뇨철고동급혈장철고동검험수평균교치료전유소하강,차이유통계학의의(P＜0.05).결론 원발성철고동증다증환자경상규치료기출상가입라내지연합급약가획득만의림상료효,유효보장기생활질량급생명안전.
Objective To investigate the clinical effect of spironolactone on primary aldosteronism.Methods The clinical data of 62 patients with primary aldosteronism disease were retrospectively analyzed.All patients received clinically conventional drug therapy combined with spironolactone.The urinary aldosterone, plasma aldosterone changes and incidence of adverse reactions before and after the treatment were recorded, and concluded by statistical analysis.Results After sixty-two patients with primary aldosteronism used spironolactone based on the conventional therapy, the urinary aldosterone and plasma aldosterone levels decreased compared with before treatment, the differences were significant (P ＜ 0.05).Conclusions The clinical efficacy of spironolactone combined with conventional treatment on patients with primary aldosteronism is satisfactory, and can effectively guarantee their quality of life and life safety.
